View Older Stories View More Recent Stories

Nov 12, 2025 12:22PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 12, 2025 12:18PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 12, 2025 12:16PM Form SCHEDULE 13G/A Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Nov 6, 2025 04:05PM GoPro Announces Third Quarter Results
Oct 24, 2025 03:40PM At Home Successfully Completes Financial Restructuring
Oct 23, 2025 07:25AM Tango Therapeutics raises $225 million in stock offering
Oct 23, 2025 07:20AM Tango Therapeutics Announces $225 Million Financing
Oct 21, 2025 08:00AM Minerva Neurosciences secures up to $200 million for schizophrenia drug trial
Oct 21, 2025 08:00AM Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and R
Oct 20, 2025 06:30AM GRAIL raises $325 million in private placement financing
Oct 20, 2025 06:30AM GRAIL, Inc. Announces $325.0 Million Private Placement Financing
Oct 14, 2025 11:44AM Bungalow Projects and Bain Capital Real Estate Close $304 Million in Construction Financing for Echelon Studios, Two State-of-the-Art Film and TV Production Studios in New York City
Oct 7, 2025 05:21PM CORRECTING and REPLACING: emeis: Results for the first half of 2025
Oct 6, 2025 05:00AM CounterpointeSRE Closes Record-Breaking $156 Million C-PACE Financing for Echelon Studios, New York City Production Studio Portfolio
Oct 1, 2025 09:00AM At Home Receives Court Approval for Financial Restructuring Plan
Sep 30, 2025 01:45AM emeis: Results for the first half of 2025
Sep 23, 2025 12:15PM emeis: Disposal Target Exceeded and Reduction of Net Debt by Nearly €700 Million
Sep 8, 2025 05:36PM Form SCHEDULE 13G Crinetics Pharmaceutical Filed by: Farallon Capital Partners, L.P.
Sep 2, 2025 08:37AM Form N-PX FARALLON CAPITAL MANAGEM For: Jun 30
Aug 29, 2025 04:28PM GoPro registers warrant resale covering 11 million shares
Aug 15, 2025 06:57PM Form SCHEDULE 13G ASSEMBLY BIOSCIENCES, Filed by: Farallon Capital Partners, L.P.
Aug 14, 2025 08:30AM Form N-PX/A FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2025 08:26AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Aug 14, 2025 08:21AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2025 08:21AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2025 08:20AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
Aug 14, 2025 08:19AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Aug 14, 2025 08:18AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Aug 14, 2025 08:17AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Aug 13, 2025 05:01PM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Aug 13, 2025 04:57PM Form SCHEDULE 13G/A Beta Bionics, Inc. Filed by: Farallon Capital Partners, L.P.
Aug 13, 2025 04:54PM Form SCHEDULE 13G/A Marblegate Acquisition Filed by: FARALLON CAPITAL MANAGEMENT LLC
Aug 12, 2025 04:10PM Form SCHEDULE 13G/A NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
Aug 12, 2025 04:04PM Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
Aug 8, 2025 08:05AM Assembly Biosciences prices $175 million equity financing with Gilead
Aug 8, 2025 08:05AM Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
Aug 4, 2025 09:01AM GoPro secures $50 million term loan from Farallon Capital
Aug 4, 2025 09:00AM GoPro Raises $50 Million Secured Term Loan
Jul 18, 2025 08:00AM Visteon appoints Marjorie Sennett to board of directors
Jul 18, 2025 08:00AM Visteon Names Marjorie Sennett to Board of Directors
Jul 18, 2025 08:00AM Visteon Names Marjorie Sennett to Board of Directors
Jul 11, 2025 06:33PM Form SCHEDULE 13G Liquidia Corp Filed by: Farallon Capital Partners, L.P.
Jul 10, 2025 01:33PM JOINT VENTURE OF FETNER PROPERTIES, MCB REAL ESTATE AND FARALLON CAPITAL MANAGEMENT CLOSE ON $209 MILLION ACQUISITION OF 240 WILLOUGHBY STREET IN FORT GREENE, BROOKLYN
Jul 3, 2025 07:09AM Form D/A Farallon Capital F5 Inve
Jul 3, 2025 07:03AM Form D/A Farallon Capital F5 Inve
Jun 30, 2025 11:49AM $252.5M financing secured for a 3.64M SF national industrial portfolio
Jun 20, 2025 02:29PM Form SCHEDULE 13G 23andMe Holding Co. Filed by: Farallon Capital Partners, L.P.
Jun 16, 2025 04:20AM At Home Group Enters Agreement to Facilitate Ownership Transition and Position Business for Long-Term Success
Jun 13, 2025 05:25PM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Jun 2, 2025 04:00AM Farallon Capital Management Releases Investor Presentation Outlining Value Creation Opportunities at T&D Holdings and the Need for Additional Independent Outside Directors
View More Recent Stories View Older Stories